Catalyst Wire Dossier Catalyst Wire Dossier

Orectalip

Oxaliplatin · Sinphar Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Orectalip, covering 2014-11-06 to 2014-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer [Phase 4]

See pricing